Visit us at booth #621 and find out how you can harness the power of autoantibody biomarkers to advance precision medicine and accelerate your neuroscience research.
Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
Brands: i-Ome® Protein Array, CTA Protein Array, Pan-Autoimmune Protein Array 1.0, OncoREX p53 Cancer Array, ImmuSAFE Protein Array